Literature DB >> 32022435

Pulmonary sclerosing pneumocytoma: Cytomorphology and immunoprofile.

Zahra Maleki1, Stephanie Muller2, Lester Layfield3, Momin T Siddiqui4, Natasha Rekhtman2, Liron Pantanowitz5.   

Abstract

BACKGROUND: Sclerosing pneumocytoma (SP) is a rare, benign pulmonary neoplasm. To the authors' knowledge, the current study is the first to evaluate the cytomorphology and immunoprofile of SP in a series.
METHODS: A total of 9 fine-needle aspiration cases of SP (7 of which were computed tomography guided and 2 of which were endobronchial ultrasound guided) including histopathology and immunohistochemistry were collected from 5 institutions.
RESULTS: The female-to-male ratio was 3.5:1, and the mean age of the patients was 54 years (range, 27-73 years). All cases presented as lung nodules, with a mean size of 2.2 cm (range, 1.1-5 cm), and were interpreted as atypical on rapid on-site evaluation. The final diagnoses were favor adenocarcinoma (1 case), well-differentiated lung adenocarcinoma (2 cases), low-grade epithelial neoplasm (2 cases), and sclerosing pneumocytoma (4 cases). Samples were moderately cellular, and consisted of round epithelioid cells with clear cell features, columnar cells, and spindle cells. A papillary arrangement with prominent hyalinized fibrovascular cores was the most common architectural pattern, followed by flat sheets and acinar formations. Tumor cells demonstrated mild, focally moderate nuclear pleomorphism with prominent nucleoli, hyperchromasia, nuclear elongation, nuclear overlap, and occasional nuclear inclusions and grooves. The background consisted of foamy macrophages (9 cases), hemosiderin pigment (6 cases), and lymphoid aggregates (3 cases) with no mitoses and/or necrosis. The surface cells and underlying round cells were positive for both thyroid transcription factor 1 and epithelial membrane antigen in all cases, which was the most notable immunohistochemical finding.
CONCLUSIONS: Cytomorphological findings of SP overlap with those of well-differentiated lung adenocarcinoma. Awareness of these cytomorphologic findings and the distinct immunoprofile of the 2 cell types found in SP should prevent a misdiagnosis and aggressive treatment.
© 2020 American Cancer Society.

Entities:  

Keywords:  fine-needle aspiration (FNA); lung mass or nodule; pulmonary neoplasm; sclerosing hemangioma; sclerosing pneumocytoma

Mesh:

Substances:

Year:  2020        PMID: 32022435      PMCID: PMC9261915          DOI: 10.1002/cncy.22251

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   4.264


  40 in total

1.  Sclerosing hemangioma (histiocytoma, xanthoma) of the lung.

Authors:  A A LIEBOW; D S HUBBELL
Journal:  Cancer       Date:  1956 Jan-Feb       Impact factor: 6.860

2.  Sclerosing hemangioma with florid endobronchial and endobronchiolar growth.

Authors:  Yoji Wani; Kenji Notohara; Choutatsu Tsukayama; Norihito Okumura
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

3.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

4.  Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma.

Authors:  Hee Jin Lee; Se Jin Jang; Sung-Min Chun; Seung-Il Park; Dong Kwan Kim; Jene Choi
Journal:  Exp Lung Res       Date:  2011-06-07       Impact factor: 2.459

5.  Respiratory arrest caused by endobronchial sclerosing hemangioma of the left main bronchus.

Authors:  M Jawad Latif; G Farah Rahman; Cliff P Connery
Journal:  J Bronchology Interv Pulmonol       Date:  2009-07

6.  Bilateral multiple pulmonary sclerosing hemangioma.

Authors:  Jun Hanaoka; Masatsugu Ohuchi; Shuhei Inoue; Satoru Sawai; Noriaki Tezuka; Shozo Fujino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-03

7.  Clinicopathological analysis of pulmonary sclerosing hemangioma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Mitsutoshi Shiba; Yukiko Haga; Yasumitsu Moriya; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

8.  Cytopathologic diagnosis of pulmonary sclerosing hemangioma.

Authors:  Anthony A Gal; Victor H Nassar; Joseph I Miller
Journal:  Diagn Cytopathol       Date:  2002-03       Impact factor: 1.582

Review 9.  So-called sclerosing hemangioma of lung: current concept.

Authors:  Neda Kalhor; Gregg A Staerkel; Cesar A Moran
Journal:  Ann Diagn Pathol       Date:  2009-12-11       Impact factor: 2.090

10.  Immunohistochemical study of so-called sclerosing haemangioma of the lung.

Authors:  H Haimoto; Y Tsutsumi; H Nagura; N Nakashima; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  1 in total

1.  Analysis of the value of enhanced CT combined with texture analysis in the differential diagnosis of pulmonary sclerosing pneumocytoma and atypical peripheral lung cancer: a feasibility study.

Authors:  Chenglong Luo; Yiman Song; Yiyang Liu; Rui Wang; Jianbo Gao; Songwei Yue; Changmao Ding
Journal:  BMC Med Imaging       Date:  2022-02-02       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.